• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

The End of the Public Health Emergency: What It Means for Telehealth

by Emily A. Johnson, JD • August 15, 2023

  • Tweet
  • Email
Print-Friendly Version

Prescribing Controlled Substances

Another exception that expired at the end of the PHE is the Drug Enforcement Administration (DEA) exception to requirements for separate DEA registrations in all states where patients being prescribed controlled substances by telehealth are located.

You Might Also Like

  • AMA Adopts Policy to Combat Public Health Disinformation by Healthcare Professionals
  • COVID-19 Pandemic: Dealing with Emergency Waivers, Provider Relief Funding, and Potential Audits
  • Masks Off: Adaptability in the Face of Emergency
  • Department of Health and Human Services’ Final Rule Expands HIPAA Obligations, Violation Penalties
Explore This Issue
August 2023

During the PHE, if a clinician was registered with the DEA in any state, they didn’t need to register in other states where they were prescribing or dispensing controlled substances via telehealth, if state law allowed. Now that the PHE has expired, clinicians once again need to register with the DEA in all states in which their patients are located.

An in-person medical evaluation is also once again required to prescribe Schedule 2–5 substances through telehealth.

Delayed Changes

Happily, many more telehealth changes post-PHE won’t take effect until the end of 2024. One telehealth policy that will remain through Dec. 31, 2024, is that clinicians can provide telehealth services to patients regardless of their geographic location. The ability to provide services across state lines has been a popular option for some practices during the pandemic; the HHS cautions, however, that this allowance is subject to individual state laws, which may prevent interstate telehealth services.

Also extended until Dec. 31, 2024, is the ability to provide telehealth services to Medicare patients in their homes, as well as providing audio-only telehealth services to patients. The HHS has provided guidance for how audio-only telehealth can remain compliant after the OCR’s enforcement discretion ends.

Importantly, clinicians should note that landlines will not violate HIPAA, whereas cell phones or other electronic communication technologies may. Clinicians should take reasonable steps to ensure their audio-only service is private, that the patient’s identity is verified, and that auxiliary aids or services are used as appropriate to ensure the effectiveness of the communication.

No Change Expected

Some telehealth changes made as a result of the PHE will remain in place permanently. Most of these changes deal with the provision of behavioral health or mental health services. However, with any of the changes made due to the PHE, it’s important to stay informed about any other extensions or guidance that may be implemented even after the end of 2024. As industries adjust their businesses post-PHE, additional action may be taken by federal or state governments to preserve telehealth changes that are popular with the general public.

The end of the public health emergency signals many changes in the healthcare industry, but among the most important will be changes to the use of telehealth. —Emily A. Johnson, JD

Pages: 1 2 3 | Single Page

Filed Under: Departments, Home Slider, Legal Matters Tagged With: COVID19, telehealthIssue: August 2023

You Might Also Like:

  • AMA Adopts Policy to Combat Public Health Disinformation by Healthcare Professionals
  • COVID-19 Pandemic: Dealing with Emergency Waivers, Provider Relief Funding, and Potential Audits
  • Masks Off: Adaptability in the Face of Emergency
  • Department of Health and Human Services’ Final Rule Expands HIPAA Obligations, Violation Penalties

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • The Road Less Traveled—at Least by Otolaryngologists

    • The Best Site for Pediatric TT Placement: OR or Office?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?
    • What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939